Race Oncology Ltd. (AU:RAC) has released an update.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Race Oncology Ltd. has announced a change in director Dr. Sergio Scrofani’s interest, with the acquisition of 58,446 unlisted options. These options are exercisable at $2.05 and will expire on November 25, 2028, following shareholder approval. This move may interest investors tracking executive decisions within the company.
For further insights into AU:RAC stock, check out TipRanks’ Stock Analysis page.
Trending Articles
- OpenAI’s Text-Video Generator Sora Leaked by Artists in Protest
- Palantir’s Gets New Street-High Price Target from Analysts on Nasdaq Shift
- ‘A Leader in the Modern Knudsen Movement’: Bank of America Applauds Palantir Stock
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
